Invasive fungal disease often plays an important role in the morbidity and mortality of
immunocompromised patients. The poor sensitivity of current fungal blood culture and histological …

The use of the 16S rRNA gene for identification of nontuberculous mycobacteria (NTM)
provides a faster and better ability to accurately identify them in addition to contributing …

The past several years have witnessed an upsurge of genomic data pertaining to the
Mycobacterium avium complex (MAC). Despite clear advances, problems with the detection of …

The taxonomic position of members of the Mycobacterium abscessus complex has been the
subject of intensive investigation and, in some aspects confusion, in recent years as a result …

The Mycobacterium avium complex consists of epidemiologically distinct subsets. The
classification of these subsets is complicated by a number of factors, including the ambiguous …

Amikacin is a major drug used for the treatment of Mycobacterium avium complex (MAC)
disease, but standard laboratory guidelines for susceptibility testing are not available. This …

Mycobacterium avium comprises organisms that share the same species designation despite
considerable genomic and phenotypic variability. To determine the degree and nature of …

Nontuberculous mycobacteria, particularly the Mycobacterium avium complex (MAC) bacteria,
are increasingly recognized as opportunistic pathogens of humans. As a result, studies on …

The clinical profile of nontuberculous mycobacteria (NTM) has been raised by the human
immunodeficiency virus and AIDS pandemic. Different laboratory techniques, often molecular …

Seventy years have passed since Ernest H. Runyon presented a phenotypic classification
approach for nontuberculous mycobacteria (NTM), primarily as a starting point in trying to …